Atlas Trials

SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer

Clinical trial NCT06908031 · COMPLETED

Trial details

NCT number
NCT06908031
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal AdenocarcinomaHigh-Risk CancerMSS
Start date
2025-04-02
Primary completion
2026-04-22
Enrollment
49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.